Literature DB >> 35812040

The homeostatic malfunction of a novel feedback pathway formed by lncRNA021545, miR-330-3p and epiregulin contributes in hepatocarcinoma progression via mediating epithelial-mesenchymal transition.

Siwen Yang1, Yunkun Zhang1, Chunmei Guo1, Rui Liu1, Maroua Elkharti1, Zhenhua Ge1, Qinlong Liu2, Shuqing Liu1, Ming-Zhong Sun1.   

Abstract

A better understanding of tumor metastasis is urgently required for the treatment and prognosis of hepatocarcinoma patients. Current work contributes a novel ceRNA feedback regulation pathway composed of epiregulin (EREG), microRNA-330-3p (miR-330-3p) and long non-coding RNA 021545 (lncRNA021545) in regulating hepatocarcinoma malignancy via epithelial-mesenchymal transition (EMT) process. Closely correlated, the deficiencies of EREG and lncRNA021545 and the overexpression of miR-330-3p were involved in the clinical progression of hepatocarcinoma. In vitro results showed that 1) lncRNA021545 downregulation promoted, 2) miR-330-3p dysexpression positively correlated, and 3) EREG dysexpression reversely correlated with the migratory and invasive properties of hepatocarcinoma HCCLM3 and Huh7 cell lines. By directly binding to EREG and lncRNA021545, miR-330-3p expression change reversely correlated with their expressions in HCCLM3 and Huh7 cells, which was also confirmed in primary tumors from HCCLM3-xenograft mice in responding to miR-330-3p change. LncRNA021545 and EREG positively regulated each other, and lncRNA021545 negatively regulated miR-330-3p, while, EREG dysregulation unchanged miR-330-3p expression in hepatocarcinoma cells. Furthermore, systemic in vitro cellular characterizations showed that the malfunctions of the three molecules mediated the invasiveness of hepatocarcinoma cells via EMT process through affecting the expressions of E-cadherin, N-cadherin, vimentin, snail and slug, which was further confirmed by in vivo miR-330-3p promotion on the tumorigenicity and metastasis of HCCLM3 bearing nude mice and by in vitro miR-330-3p promotion on the migration and invasion of hepatocarcinoma cells to be antagonized by EREG overexpression through acting on EMT process. Our work indicates, that by forming a circuit signaling feedback pathway, the homeostatic expressions of lncRNA021545, miR-330-3p and EREG are important in liver health. Its collapse resulted from the downregulations of lncRNA021545 and EREG together with miR-330-3p overexpression promote hepatocarcinoma progression by enhancing the invasiveness of tumor cells through EMT activation. These discoveries suggest that miR-330-3p/lncRNA021545/EREG axis plays a critical role in hepatocarcinoma progression and as a candidate for its treatment. AJCR
Copyright © 2022.

Entities:  

Keywords:  EMT; EREG; Hepatocarcinoma; lncRNA021545; miR-330-3p

Year:  2022        PMID: 35812040      PMCID: PMC9251696     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  77 in total

1.  Epithelial-mesenchymal transition events during human embryonic stem cell differentiation.

Authors:  Angela M Eastham; Helen Spencer; Francesca Soncin; Sarah Ritson; Catherine L R Merry; Peter L Stern; Christopher M Ward
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

Review 2.  EMT: 2016.

Authors:  M Angela Nieto; Ruby Yun-Ju Huang; Rebecca A Jackson; Jean Paul Thiery
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

3.  High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.

Authors:  Cheng-Yi Lin; Pei-Ling Hsieh; Chia-Lin Chou; Ching-Chieh Yang; Sung-Wei Lee; Yu-Feng Tian; Yow-Ling Shiue; Wan-Shan Li
Journal:  Oncology       Date:  2020-05-14       Impact factor: 2.935

4.  An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis.

Authors:  Xiayu Rao; Xuelin Huang; Zhicheng Zhou; Xin Lin
Journal:  Biostat Bioinforma Biomath       Date:  2013-08

5.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

6.  Epiregulin (EREG) variation is associated with susceptibility to tuberculosis.

Authors:  N T T Thuong; T R Hawn; T T H Chau; N D Bang; N T B Yen; G E Thwaites; Y Y Teo; M Seielstad; M Hibberd; N T N Lan; M Caws; J J Farrar; S J Dunstan
Journal:  Genes Immun       Date:  2011-12-15       Impact factor: 2.676

Review 7.  The rise of regulatory RNA.

Authors:  Kevin V Morris; John S Mattick
Journal:  Nat Rev Genet       Date:  2014-04-29       Impact factor: 53.242

8.  Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial.

Authors:  Sebastian Stintzing; Boryana Ivanova; Ingrid Ricard; Andreas Jung; Thomas Kirchner; Andrea Tannapfel; Hendrik Juette; Susanna Hegewisch-Becker; Dirk Arnold; Anke Reinacher-Schick
Journal:  Front Oncol       Date:  2018-11-08       Impact factor: 6.244

9.  Macrophages activate mesenchymal stem cells to acquire cancer-associated fibroblast-like features resulting in gastric epithelial cell lesions and malignant transformation in vitro.

Authors:  Qiang Zhang; Shuo Chai; Wei Wang; Chengcheng Wan; Feng Zhang; Yuyun Li; Fengchao Wang
Journal:  Oncol Lett       Date:  2018-11-15       Impact factor: 2.967

10.  Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation.

Authors:  Chen Yang; Zezhong Mou; Zheyu Zhang; Siqi Wu; Quan Zhou; Yiling Chen; Jian Gong; Chenyang Xu; Yuxi Ou; Xinan Chen; Xiyu Dai; Haowen Jiang
Journal:  Mol Ther Nucleic Acids       Date:  2021-01-16       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.